EUVIMEDAtrasti EUVIMED
Crossref

LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma

Yifan Wen iD, Shuo Liu, Zhen Qin, Jingshu Cai, Lingfei Jia iD, Xin Peng iD

Molecular Carcinogenesis · 2026-07 · 65 (7) · 795-806

DOI: 10.1002/mc.70117 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-04-08. Written by Yifan Wen and 5 co-authors. Institution: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China. Major MEDLINE topics: Proto-Oncogene Proteins c-myc, RNA, Long Noncoding, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms. Cited 1 times so far (Crossref); 38 references. Funded by: National Natural Science Foundation of China, Research Foundation of Peking University School, Hospital of Stomatology.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Small‐molecule MYC inhibitors that directly target MYC are considered attractive cancer therapeutics. Here, we demonstrate that LUCAT1, a long noncoding RNA, serves as a critical mediator of MYC‐driven signaling in head and neck squamous cell carcinoma (HNSCC). The LUCAT1 expression is significantly downregulated in HNSCC cells following treatment with the MYC inhibitor MYCi975. Mechanically, MYC transcriptionally activates LUCAT1 through direct promoter binding, facilitating oncogenic functions. Clinically, elevated LUCAT1 is linked to cervical lymph node involvement in HNSCC and is associated with unfavorable patient outcomes. Functional studies in vitro demonstrated that LUCAT1 knockdown inhibits proliferation, migratory capacity, and invasive activity of HNSCC cells. This suppression also extends to the in vivo growth of tumors. Importantly, LUCAT1 overexpression attenuates the MYCi975 anti‐tumor effects on HNSCC, confirming its role in therapeutic resistance. These results establish LUCAT1 as both a biomarker of aggressive disease and a mediator of MYC‐driven oncogenesis, proposing LUCAT1 as a candidate synergistic therapeutic target in the treatment of HNSCC with MYC inhibition.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins c-mycRNA, Long NoncodingGene Expression Regulation, NeoplasticHead and Neck NeoplasmsCarcinoma, Squamous CellSquamous Cell Carcinoma of Head and NeckHumansAnimalsCell ProliferationCell Line, TumorMiceCell MovementXenograft Model Antitumor Assays

Author keywords

LUCAT1MYCMYCi975head and neck squamous cell carcinomalong non‐coding RNA

Substances

Proto-Oncogene Proteins c-mycRNA, Long NoncodingMYC protein, humanlong non-coding RNA LUCAT1, human

Authors and institutions

  • Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
  • National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing, China.
  • Inner Mongolia Medical University, Hohhot, China.

ORCID profiles: Yifan Wen, Lingfei Jia, Xin Peng

Funding

  • National Natural Science Foundation of China
  • Research Foundation of Peking University School
  • Hospital of Stomatology

Cite

APA

Wen, Y., Liu, S., Qin, Z., Cai, J., Jia, L., & Peng, X. (2026). LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma. Molecular Carcinogenesis, 65(7), 795-806. https://doi.org/10.1002/mc.70117

Vancouver

Wen Y, Liu S, Qin Z, Cai J, Jia L, Peng X. LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma. Molecular Carcinogenesis. 2026;65(7):795-806. doi:10.1002/mc.70117

BibTeX
@article{Wen2026,
  author = {Wen, Yifan and Liu, Shuo and Qin, Zhen and Cai, Jingshu and Jia, Lingfei and Peng, Xin},
  title = {LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {7},
  pages = {795--806},
  doi = {10.1002/mc.70117}
}
Start for free →